A retrospective, cohort study identify and characterize trajectories of bDMARDs in RA patients
Latest Information Update: 15 Sep 2021
At a glance
- Drugs Abatacept (Primary) ; Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 25 Aug 2021 Results presented at the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 09 Dec 2020 New trial record